Trends in Partial Disability-Free Life Expectancy between the Ages of 45 and 70 in Canada, 2000–2014

Author(s):  
Judith Lefebvre ◽  
Yves Carrière

Abstract To better evaluate the benefits of a possible increase in the normal retirement age, this article proposes to examine recent trends in the health status of Canadians between 45 and 70 years of age. Using the Sullivan method, trends from 2000 to 2014 in partial disability-free life expectancy (PDFLE) between the ages of 45 and 70 years are computed. Disability is estimated using attributes of the Health Utility Index correlated with the capacity to work, and is looked at by level of severity. Data from the Canadian Community Health Survey were used to estimate the prevalence of disability. Results reveal a slight increase in partial life expectancy between the ages of 45 and 70, and a larger number of those years spent in poor health since the beginning of the 2000s. Hence, this study brings no evidence in support of the postponement of the normal retirement age if this policy were solely based on gains in life expectancy.

Author(s):  
Ellen Kuenzig ◽  
Doug Manuel ◽  
Jessy Donelle ◽  
Eric Benchimol

IntroductionInflammatory bowel disease (IBD) is a chronic immune-mediated disease of the gastrointestinal tract. Significant improvements in treatments for IBD have occurred in the past two decades. However, the benefits of new treatments on mortality is uncertain and no prior study has evaluated the life expectancy (LE) of patients with IBD. Objectives and ApproachWe determined trends in the LE and health-adjusted life expectancy (HALE) in IBD. The Ontario Crohn’s and Colitis Cohort includes all patients in Ontario with IBD, identified from health administrative data using a previously validated algorithm. Cases were matched to five controls based on age, sex, rural/urban, and mean neighbourhood income quintile. Period life tables were used to calculate LE on July 1, 1996, 2000, and 2008. The Canadian National Population Health Survey (1996/97) and Canadian Community Health Survey (Cycles 1.1 and 2009/10) were used to estimate health utility index (HUI3). HALE was estimated using HUI3-weighted disability-free years lived. ResultsLE increased from 75.5 years (y) in 1996 to 78.0y in 2008 among women with IBD (∆2.5y, 95%CI 0.8 to 4.1) and from 72.2y in 1996 to 75.1y in 2008 among men with IBD (∆2.9y, 95%CI 1.8 to 4.0). HALE decreased among men with IBD (∆3.9y, 95%CI 1.2 to 6.6; 1996: 67.0y; 2008: 63.1y) but was stable among women with IBD (∆2.0y, 95%CI -1.6 to 5.7; 1996: 62.3y; 2008: 64.3y) and female controls (∆-0.4y, 95%CI -2.3 to 1.5; 1996: 74.3y; 2008: 73.9y) and male controls (∆0.2y, 95%CI -1.7 to 2.2; 1996: 69.6y; 2008: 69.8y). LE and HALE in both men and women with IBD were significantly decreased compared to controls (LE: women ∆6-8y, men ∆5y; HALE: women ∆10-14y, men ∆3-7y). Conclusion/ImplicationsAlthough patients with IBD experienced increases in LE at a pace similar to those without IBD, the gap in LE between cases and controls remains significant. Increases in LE have not been accompanied by increases in HALE. Treatments that increase both LE and HALE in patients with IBD are needed.


Author(s):  
Kristianne Chelsea Altura ◽  
Scott B. Patten ◽  
Jeanne V. A. Williams ◽  
Kirsten M. Fiest ◽  
Nathalie Jetté

ABSTRACT:Objective: To develop a detailed profile of individuals living with migraine in Canada. Such a profile is important for planning and administration of services. Methods: The 2011–2012 Survey of Living with Neurological Conditions in Canada (SLNCC), a cross-sectional community-based survey, was used to examine a representative sample of migraineurs (N = 949) aged 15 years and older. Several health-related variables were examined (e.g., general health, health utility index (HUI) [a measure of health status and health-related quality of life, where dead = 0.00 and perfect health = 1.00], stigma, depression, and social support). Respondents were further stratified by sex, age, and age of migraine onset. Weighted overall and stratified prevalence estimates and odds ratios, both with 95% CIs, were used to estimate associations. Results: Overall, males had poorer health status compared with females (e.g., mean HUI was 0.67 in males vs. 0.82 in females; men had over two times the odds of their migraine limiting educational and job opportunities compared with females). Poorer health-related variables were seen in the older age groups (35–64 years/≥65 years) compared with the 15–34-year age group. There were no differences between those whose migraine symptoms began before versus after the age of 20 years. Conclusions: In this Canadian sample, migraine was associated with worse health-related variables in men compared with women. However, both men and women were significantly affected by migraine across various health-related variables. Thus, it is important to improve clinical and public health interventions addressing the impact of migraine across individuals of all ages, sexes, and sociodemographic backgrounds.


2020 ◽  
pp. 1-15
Author(s):  
Soha Metwally

Abstract This study aimed to estimate among the older population in Egypt (aged 60 years and over): 1) disability prevalence rates, their levels of severity and the common types and 2) disability-free life expectancy (DFLE) by sex, age and disability type. Data were from the nationally representative 2016 Household Observatory Survey (HOS-2016), with 4658 persons aged 60+ constituting the study sample population. To identify individuals with disabilities, the HOS asked respondents a short set of questions on functional difficulties, as suggested by the United Nations Washington Group on Disability Statistics. The DFLE was estimated using the Sullivan method. Older (60+) women reported a higher prevalence of disability than older men. Women had longer DFLEs and longer disabled life expectancies (DLEs) than men but had lower proportions of DFLE to their total lifetime. The findings suggest that, at age 60, around 30% of life expectancy in Egypt can be expected to be with limitations in mobility and vision. Men, although they live for fewer years than women, can expect to have a greater proportion of their life expectancy free of disability. The findings of the study suggest that the contextual differences in how the process of ageing is experienced need to be considered by decision-makers when designing gender-responsive health policies.


2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Lidia Loukine ◽  
Chris Waters ◽  
Bernard C. K. Choi ◽  
Joellyn Ellison

Hypertension can lead to cardiovascular diseases and other chronic conditions. While the impact of hypertension on premature death and life expectancy has been published, the impact on health-adjusted life expectancy has not, and constitutes the research objective of this study. Health-adjusted life expectancy (HALE) is the number of expected years of life equivalent to years lived in full health. Data were obtained from the Canadian Chronic Disease Surveillance System (mortality data 2004–2006) and the Canadian Community Health Survey (Health Utilities Index data 2000–2005) for people with and without hypertension. Life table analysis was applied to calculate life expectancy and health-adjusted life expectancy and their confidence intervals. Our results show that for Canadians 20 years of age, without hypertension, life expectancy is 65.4 years and 61.0 years, for females and males, respectively. HALE is 55.0 years and 52.8 years for the two sexes at age 20; and 24.7 years and 22.9 years at age 55. For Canadians with hypertension, HALE is only 48.9 years and 47.1 years for the two sexes at age 20; and 22.7 years and 20.2 years at age 55. Hypertension is associated with a significant loss in health-adjusted life expectancy compared to life expectancy.


2013 ◽  
Vol 33 (1) ◽  
pp. 293-311 ◽  
Author(s):  
Karine Pérès ◽  
Arlette Edjolo ◽  
Jean-François Dartigues ◽  
Pascale Barberger-Gateau

2007 ◽  
Vol 32 (2) ◽  
pp. 198-202 ◽  
Author(s):  
I. ATROSHI ◽  
C. GUMMESSON ◽  
S. J. MCCABE ◽  
E. ORNSTEIN

Cost effectiveness is an important factor to consider when choosing between various hand surgical interventions. Health utility measures can be used to determine cost effectiveness. The SF-6D is a health utility index derived from 11 items of the SF-36 quality of life questionnaire; values range from 0.296 to 1.0 (“perfect” health). We evaluated the validity of the SF-6D in patients with carpal tunnel syndrome (CTS) who completed the SF-36 and the CTS symptom severity and functional status questionnaire before and 3 months after carpal tunnel release. Complete responses to the SF-6D items were available for 100 patients at baseline and 95 patients at baseline and follow-up. The mean SF-6D health utility index was 0.69 (SD 0.13) before surgery and 0.77 (SD 0.13) after surgery (moderate effect size). The SF-6D could discriminate between patient groups differing in self-rated global health and in whether, or not, they had a minimal clinically important improvement in CTS symptom severity after surgery. The SF-6D appears to be a valid measure of health utilities in patients with CTS and can be used in cost effectiveness studies.


Sign in / Sign up

Export Citation Format

Share Document